X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (140) 140
index medicus (105) 105
male (98) 98
female (97) 97
middle aged (96) 96
hematology (85) 85
aged (78) 78
adult (77) 77
oncology (58) 58
treatment outcome (53) 53
cancer (52) 52
leukemia, myeloid, acute - drug therapy (51) 51
life sciences (39) 39
acute myeloid leukemia (37) 37
chemotherapy (37) 37
prognosis (37) 37
aged, 80 and over (36) 36
leukemia, myeloid, acute - genetics (34) 34
adolescent (29) 29
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
leukemia, myeloid, acute - pathology (28) 28
abridged index medicus (27) 27
leukemia, myeloid, acute - mortality (27) 27
acute myeloid-leukemia (26) 26
young adult (25) 25
leukemia (24) 24
animals (22) 22
disease-free survival (21) 21
immunology (21) 21
retrospective studies (20) 20
survival analysis (20) 20
mutation (19) 19
mice (18) 18
recurrence (18) 18
survival (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
france (17) 17
remission induction (17) 17
therapy (17) 17
aml (16) 16
elderly-patients (15) 15
hemic and lymphatic diseases (15) 15
human necessities (15) 15
hygiene (15) 15
leukemia, myeloid, acute - diagnosis (15) 15
medical or veterinary science (15) 15
preparations for medical, dental, or toilet purposes (15) 15
risk factors (15) 15
apoptosis (14) 14
expression (14) 14
follow-up studies (14) 14
analysis (13) 13
diagnosis (13) 13
intensive chemotherapy (13) 13
kaplan-meier estimate (13) 13
specific therapeutic activity of chemical compounds ormedicinal preparations (13) 13
survival rate (13) 13
activation (12) 12
azacitidine (12) 12
chemistry (12) 12
cytarabine (12) 12
cytogenetics (12) 12
hematology, oncology and palliative medicine (12) 12
leukemia, myeloid, acute - metabolism (12) 12
metallurgy (12) 12
prospective studies (12) 12
stem-cell transplantation (12) 12
trial (12) 12
acute myelogenous leukemia (11) 11
adhesive processes not provided for elsewhere (11) 11
adhesives (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
article (11) 11
basic electric elements (11) 11
care and treatment (11) 11
compositions based thereon (11) 11
cytarabine - administration & dosage (11) 11
dyes (11) 11
electric solid state devices not otherwise provided for (11) 11
electricity (11) 11
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (11) 11
miscellaneous applications of materials (11) 11
miscellaneous compositions (11) 11
natural resins (11) 11
non-mechanical aspects of adhesive processes in general (11) 11
organic macromolecular compounds (11) 11
paints (11) 11
polishes (11) 11
research (11) 11
semiconductor devices (11) 11
their preparation or chemical working-up (11) 11
time factors (11) 11
use of materials as adhesives (11) 11
antimetabolites, antineoplastic - therapeutic use (10) 10
antineoplastic agents - pharmacology (10) 10
cell line, tumor (10) 10
cohort studies (10) 10
drug administration schedule (10) 10
mutations (10) 10
older patients (10) 10
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (381) 381
French (24) 24
German (11) 11
Chinese (3) 3
Korean (2) 2
Norwegian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESPONSE CRITERIA | AGGRESSIVE LYMPHOMAS | POOR-PROGNOSIS | NON-HODGKINS-LYMPHOMA | REGIMEN | YOUNG-PATIENTS | ELDERLY-PATIENTS | DES-LYMPHOMES | TRANSPLANTATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials | Life Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1025 - 1036
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2737 - 2737
Abstract Relapses in acute myeloid leukemia (AML) are caused by chemoresistant leukemic populations and new therapeutic approaches that specifically target... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1449 - 1449
Abstract After intensive chemotherapy, the emergence of cells with drug resistant and/or stem cell features might explain frequent relapses and the poor... 
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2007, Volume 357, Issue 11, pp. 1083 - 1093
Journal Article
BMC CANCER, ISSN 1471-2407, 09/2019, Volume 19, Issue 1, pp. 883 - 12
Background Evidences support social inequalities in cancer survival. Studies on hematological malignancies, and more specifically Acute Myeloid Leukemia (AML),... 
CANCER SURVIVAL | DIAGNOSIS | Observational study | INTENSIVE CHEMOTHERAPY | STAGE | SOCIOECONOMIC INEQUALITIES | TIME | Elderly patients | CARE | French European deprivation index | IMPACT | Cancer management and survival | DISPARITIES | ONCOLOGY | Acute myeloid leukemia
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5238 - 5238
Abstract Isocitrate dehydrogenases IDH1/2 mutations and its oncometabolite 2-HG have been of major clinical interest as they have been causally linked to the... 
Journal Article